CONVERTING CELLS INTO CELLULAR FACTORIES  by Alper, Hal S.
  
  
 
 
 
This special issue focusses on the theme of metabolic 
engineering and the design of cellular factories.  This is a very 
timely issue given that we sit at a newly developing nexus 
between systems biology understanding and synthetic biology 
design and construction [1].  The tangible result of these forces 
is a newfound capacity to rapidly produce an expanding array 
of new molecules in recombinant organisms [2].  It was not 
long ago that the list of metabolic engineering feats was small 
and limited to mostly natural metabolites such as ethanol, 
lysine, glutamic acid, and carotenoids.  Now, this list includes 
molecules that can be used as fuels, polymer precursors, 
pharmaceuticals, and commodity/specialty chemicals.  Both the 
number and chemical diversity of molecules continues to 
increase rapidly.  We are quickly moving to an era where it is 
conceivable to produce any desired organic molecule in a 
cellular system.  The papers in this special issue highlight the 
rapid expansion of both product and organismal diversity that 
is being seen in research across the field.  The early years of 
metabolic engineering were focused on rewiring endogenous 
metabolism to overproduce native metabolites such as ethanol 
and amino acids.  Now, we must tackle a wider array of non-
native metabolites including large-chain alcohols, complex 
polymers, and natural products.  These feats require 
sophisticated genetic control along with new enzymes and 
pathways (both imported as well as synthetic).  At the 
organismal level, our systems biology understanding and 
advanced molecular biology has enabled our move beyond 
model organisms and into exotic yeasts, photosynthetic 
organisms, and even into electrotrophs.  While these organisms 
certainly raise new challenges for modern molecular biology, 
they provide promising biotechnological traits.  The thought of 
forming a new company around a novel organism with the 
hopes of being able to eventually perform the required genetic 
engineering used to be very risky.  Now, such a proposition is 
quite commonplace. 
 
 
 
 
 
 
 
 
 
 
 
As stated above, we are entering a time when systems 
biology is truly beginning to collide with synthetic biology.  Put 
another way, our understanding of cellular complexity is 
beginning to be matched with our ability to engineer synthetic 
metabolism and regulation.  This combination of strengths will 
be quite fruitful for the field of metabolic engineering.  For 
example, several articles in this issue take advantage of genome 
scale models for the prediction of metabolic engineering targets.  
Systems level understanding of cellular function and automated 
methods for developing genome scale models rapidly expands 
the metabolic engineering toolkit.  The progression of 
identifying a unique strain, sequencing the genome, and 
assembling a genome-scale model has progressed rapidly in the 
past few years and has become financially and intellectually 
tangible, even for a single researcher.  Until recently, such 
intricate knowledge of cellular metabolism has been limited to 
only well-studied model organisms.  Integrating this 
information in the form of a genome-scale model helps 
researchers parse the interconnectedness of cellular metabolism.  
These models both predict genetic modification as well as 
establish bounds of metabolism.  The latter can help in 
selecting the ideal organism for a given task. 
 
Beyond model-guided metabolic engineering, we are 
beginning to witness an expanded capacity to engineer synthetic 
function in cells.  The interface of synthetic biology with 
metabolic engineering offers the ability to design control 
system, create new metabolic pathways, and import metabolic 
modules.  This work is also inherent in some of the papers in 
this special issue.  In particular, the rapid expansion in our 
capacity to make natural products and non-native molecules is 
predicated by our ability to import and control synthetic 
metabolic pathways.  These skills have enabled the rapid 
expansion we see in the molecules produced by cellular 
factories. 
 
The themes of systems biology and synthetic biology are 
interwoven throughout the papers for this special issue.  They 
represent the state-of-the-art in designing, optimizing, and 
engineering cells.  The end goal of transforming cellular systems 
into a cellular factory is not always easy to attain.  Yet, an 
increase in our capacity to understand and alter cells continues 
to make this feat ever-attainable.  The rapid expansion in both 
molecules produced and cell types engineered shows the 
promise inherent in the goals of metabolic engineering.  In time, 
these approaches will lead to a new industrial biotechnological 
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 revolution in which all organic molecules of interest can be 
made via cellular processes.  Given the great strides taking place 
in the field, that time is not too far away. 
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